NDC 0003-3641 – Evotaz

Atazanavir Sulfate 300 mg/1; Cobicistat 150 mg/1 · Tablet · Oral

Human Prescription Drug

Product NDC0003-3641

Product details

Brand name
Evotaz
Generic name
Atazanavir and cobicistat
Labeler
E.R. Squibb & Sons, L.L.C.
Dosage form
Tablet
Route
Oral
Marketing category
NDA · NDA206353
Marketed since
January 29, 2015
Listing expires
December 31, 2026
Pharmacologic class
Cytochrome P450 3A Inhibitor; Protease Inhibitor

Active ingredients

Uses, dosage, side effects and warnings for Evotaz →

Package NDC codes (1)

Package NDCDescriptionSince
0003-3641-1130 TABLET in 1 BOTTLE (0003-3641-11)Jan 29, 2015